Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.
By G. Bellani, J. Laffey, T. Pham, E. Fan, L. Brochard, A. Esteban, L. Gattinoni, F. V. van Haren, A. Larsson, D. McAuley and 6 more. Journal of the American Medical Association (JAMA), 2016
4,920 citations recorded by the source corpus.
IMPORTANCE Limited information exists about the epidemiology, recognition, management, and outcomes of patients with the acute respiratory distress syndrome (ARDS). OBJECTIVES To evaluate intensive care unit (ICU) incidence and outcome of ARDS and to assess clinician recognition, ventilation management, and use of adjuncts-for example prone positioning-in routine clinical practice for patients fulfilling the ARDS Berlin Definition. DESIGN, SETTING, AND PARTICIPANTS The Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) was an international, multicenter, prospective cohort study of patients undergoing invasive or noninvasive ventilation, conducted during 4 consecutive weeks in the winter of 2014 in a convenience sample of 459 ICUs from 50 countries across 5 continents. EXPOSURES Acute respiratory distress syndrome. MAIN OUTCOMES AND MEASURES The primary outcome was ICU incidence of ARDS. Secondary outcomes included assessment of clinician recognition of ARDS, the application of ventilatory management, the use of adjunctive interventions in routine clinical practice, and clinical outcomes from ARDS. RESULTS Of 29,144 patients admitted to participating ICUs, 3022 (10.4%) fulfilled ARDS criteria. Of these, 2377 patients developed ARDS in the first 48 hours and whose respiratory failure was managed with invasive mechanical ventilation. The period prevalence of mild ARDS was 30.0% (95% CI, 28.2%-31.9%); of moderate ARDS, 46.6% (95% CI, 44.5%-48.6%); and of severe ARDS, 23.4% (95% CI, 21.7%-25.2%). ARDS represented 0.42 cases per ICU bed over 4 weeks and represented 10.4% (95% CI, 10.0%-10.7%) of ICU admissions and 23.4% of patients requiring mechanical ventilation. Clinical recognition of ARDS ranged from 51.3% (95% CI, 47.5%-55.0%) in mild to 78.5% (95% CI, 74.8%-81.8%) in severe ARDS. Less than two-thirds of patients with ARDS received a tidal volume 8 of mL/kg or less of predicted body weight. Plateau pressure was measured in 40.1% (95% CI, 38.2-42.1), whereas 82.6% (95% CI, 81.0%-84.1%) received a positive end-expository pressure (PEEP) of less than 12 cm H2O. Prone positioning was used in 16.3% (95% CI, 13.7%-19.2%) of patients with severe ARDS. Clinician recognition of ARDS was associated with higher PEEP, greater use of neuromuscular blockade, and prone positioning. Hospital mortality was 34.9% (95% CI, 31.4%-38.5%) for those with mild, 40.3% (95% CI, 37.4%-43.3%) for those with moderate, and 46.1% (95% CI, 41.9%-50.4%) for those with severe ARDS. CONCLUSIONS AND RELEVANCE Among ICUs in 50 countries, the period prevalence of ARDS was 10.4% of ICU admissions. This syndrome appeared to be underrecognized and undertreated and associated with a high mortality rate. These findings indicate the potential for improvement in the management of patients with ARDS. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT02010073.
Subfields: Critical Care and Intensive Care Medicine, Epidemiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/1e5f7617ec5c4eee44d2abe12c65410ff31a86ff
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Critical Care and Intensive Care Medicine
In Epidemiology
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study (2020, result): “For instance, ICU length of stay in patients surviving severe ARDS was 26 (13–43) days, compared to 14 (7–23) days in the LUNG-SAFE study [17].”
- Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure. (2017, background): “In addition, a strong indicator of ARDS severity is the ratio of dead space to tidal volume (28), which has a direct and strong influence on minute ventilation.”
- Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer (2017, background): “While mortality rates have fallen with modifications in mechanical ventilation, they remain as high as 25-40% and no effective pharmacological treatments are available((1-3)).”
- The intensive care medicine research agenda for airways, invasive and noninvasive mechanical ventilation (2017, background): “LUNG SAFE data on the one hand confirm that higher PEEP is associated with improved outcome [37], but on the other also show the reluctance of clinicians to increase PEEP and a tendency to favor raising the inspired oxygen fraction to correct hypoxemia [38].”
- Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations (2020, neutral): “The traditional pace of research might not match the pace of the outbreak NIV might reduce intubation and mortality in mild ARDS, 38 it is associated with higher mortality in moderate-to-severe ARDS from multiple causes, 39 and a high risk of failure in MERS.”